Skip to content

PLoS Medicine

ISSN 1549-1676

3 papers in the library · 5 citations · publishing 2025-2026

Papers

Sort Most recent Most cited

Cost-effectiveness of esketamine versus alternative treatment strategies for treatment-resistant depression in Hong Kong: A multi-armed modeling study.

PLoS Medicine April 1, 2026 Yifan Li, Vivien Kin Yi Chan, Mark Jit et al.

Treatment-resistant depression (TRD), defined as failure to respond to at least two adequately administered antidepressant (AD) regimens, imposes major clinical and economic burdens. Esketamine nasal spray offers rapid antidepressant clinical effects, yet previous evaluations compared it only with unrealistic comparators such as AD monotherapy. This study assessed the cost-effectiveness of...

Hospital-based care for hallucinogens and risk of mania and bipolar disorder: A population-based cohort study.

PLoS Medicine December 1, 2025 Daniel T. Myran, Rachael MacDonald-Spracklin, Michael Pugliese et al.

Hallucinogen use for both recreational and medical purposes is rapidly increasing globally, raising concerns about potential adverse effects. This study examined the risk of incident mania or bipolar disorder (BD) diagnosis associated with having an emergency department (ED) visit or hospitalization involving hallucinogens. We used a population-based cohort study of all individuals aged 14-65...

Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial

PLoS Medicine September 19, 2025 Benjamin R. Lewis, John Hendrick, Kevin Byrne et al. 5 citations

Background Depression and burnout, which are common among healthcare workers, were exacerbated by the COVID-19 pandemic. Mindfulness-Based Stress Reduction (MBSR) and psilocybin have been reported to reduce depressive symptoms, but the efficacy of the combination requires comparison to an active treatment control. We sought to evaluate the safety and preliminary efficacy of psilocybin and MBSR...